title: Host response in tumor diagnosis and prognosis: importance of immunologists and pathologists alliance.
abstract: Pathologists and immunologists have collaborated over many years in their efforts to understand and properly diagnose cancer. The ability of pathologists to correctly diagnose this disease was facilitated by the development of immunohistology that utilized specificity of antibodies to distinguish between normal cells and cancer cells. Further boost was provided through the advent of monoclonal antibodies. The two disciplines are now together on the brink of a paradigm shift resulting from a better understanding of the importance for cancer diagnosis and prognosis to consider not only the characteristics of the cancer cells, but also the cancer microenvironment reflecting the host response to the disease. This new immunology and pathology alliance named "Immunoscore" will advance research in both disciplines as well as benefit patients.
authors.affiliation: University of Pittsburgh School of Medicine, Pittsburgh, PA 15232, USA. ojfinn@pitt.edu
authors.forename: Olivera J
authors.initials: OJ
authors.lastname: Finn
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis* / Q000276:immunology / Q000378:metabolism; D000486:Allergy and Immunology; D014408:Biomarkers, Tumor / Q000378:metabolism; D003110:Colonic Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000378:metabolism; D005260:Female; D006801:Humans; D007400:Interprofessional Relations; D016246:Lymphocytes, Tumor-Infiltrating; D008297:Male; D018396:Mucin-1 / Q000378:metabolism; D010336:Pathology; D010348:Patient Care Team; D011379:Prognosis; D012017:Referral and Consultation; D046888:Tissue Array Analysis
chemical_list: D014408:Biomarkers, Tumor; C060192:MUC1 protein, human; D018396:Mucin-1